Are you from this Company?
GENSCRIPT BIOTECH CORPORATION
New Jersey, USA
2002
$101MN to $500MN
Enterprise
40 Likes
84 Buyers Negotiating
Strengths
  • +7
    Antibodies
  • +7
    Manufacturing excellence for high quality
  • +10
    Primary Antibodies
  • +8
    Mouse
  • +9
    Rabbit
  • +12
    Primary Antibody
  • +11
    Secondary Antibodies
  • +12
    Customized Antibodies
  • +10
    Other organism
  • +13
    Secondary Antibody
  • +14
    Reagent
  • +8
    End user adoption
  • +10
    Brand name contributing to revenue
  • +9
    Brand Recognition
  • +8
    Reagents
  • +14
    Solutions and Buffers
  • +5
    Stains and Dyes
  • +8
    Breadth and Depth of Product Offerings
  • +6
    R&D expenditure
  • +5
    Product launches in last 5 years
Cautions
  • -6
    Other Reagents
  • -9
    Focus on Product Innovation
  • -11
    Product Branding
  • -10
    Product Quality and Reliability
I agree to 360Quadrants Terms of use and privacy policy
Success
info
Error
Company Size :
  Enterprise
  SME
  Startup